Bleeding Risks Still A Concern For Patients With Endologix Stent Grafts: FDA Advisory Panel
Company’s latest design fails to convince panel leakage issues have been fixed
Executive Summary
The US agency’s Circulatory System Devices Panel found type III endoleaks are still a problem for abdominal aortic aneurysm patients treated with the newest Endologix stent graft, though for some the benefits still outweigh the risks. The panel advised that all patients, however, should continue getting annual screenings.